O-1125
From Self-sufficiency
| 240px | |
| Systematic (IUPAC) name | |
|---|---|
|
6-[(6aR,10aR)-1-hydroxy-6,6,9-trimethyl-6a,7,10,10a-tetrahydrobenzo[c]chromen-3-yl]-N,N,6-trimethylheptanamide | |
| Identifiers | |
| PubChem | CID 9909689 |
| Chemical data | |
| Formula | C26H39NO3 |
| Molar mass | 413.591 g/mol[[Script error: No such module "String".]] |
| Script error: No such module "collapsible list". | |
O-1125 (3-(1,1-dimethylhexyl-6-dimethylcarboxamide)-Δ8-tetrahydrocannabinol) is a drug which is a cannabinoid derivative. It has analgesic effects and is used in scientific research. It is a potent CB1 full agonist with a Ki of 1.16nM.[1]
| 40px | This article about a cannabinoid is a stub. You can help ssf by expanding it. |
References
- ↑ Griffin G, Wray EJ, Martin BR, Abood ME. Cannabinoid agonists and antagonists discriminated by receptor binding in rat cerebellum. British Journal of Pharmacology. 1999 Oct;128(3):684-8. PMID 10516649
Categories:
- Pages with script errors
- Pages with broken file links
- Infobox drug tracked parameters
- Chemical articles without CAS Registry Number
- Articles without EBI source
- Chemical pages without ChemSpiderID
- Chemical pages without DrugBank identifier
- Articles without KEGG source
- Articles without InChI source
- Articles without UNII source
- Drugboxes with an unspecified ATC code
- Drugs with no legal status
- Articles containing unverified chemical infoboxes
- Cannabinoid stubs
- Cannabinoids
- Benzochromenes
- Phenols
- Amides
- 2Fix
